Anubis Barcelona
NDC 83021-546, DMAE, concentrate, from ANUBIS COSMETICS SL.
- Product NDC
- 83021-546
- Status
- Listed
- Labeler
- ANUBIS COSMETICS SL
- Dosage form
- CONCENTRATE
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH FINAL
- Application
- M016
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/83021-546 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLYCERIN.555 g/30mL
- PHENOXYETHANOL.243 g/30mL
- XANTHAN GUM.09 g/30mL
- FRAGRANCE 13576.027 g/30mL
- SORBITAN ISOSTEARATE.024 g/30mL
- HYDROLYZED BOVINE ELASTIN (BASE.0012 g/30mL
- 1000 MW).0009 g/30mL
- LIMONENE, (+)-.0003 g/30mL
- TOCOPHEROL.0006 g/30mL
- HYDROXYCITRONELLAL.024 g/30mL
- POLYSORBATE 60.45 g/30mL
- LECITHIN, SOYBEAN.405 g/30mL
- HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER (100000 MPA.S AT 1.5%).021 g/30mL
- DEHYDROACETIC ACID1.08 g/30mL
- PROPANEDIOL.9 g/30mL
- DICAPRYLYL ETHER.036 g/30mL
- BENZOIC ACID.15 g/30mL
- ASCORBYL GLUCOSIDE25.5564 mL/30mL
- WATER
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Nitrogen Binding Agent [EPC]; Non-Standardized Chemical Allergen [EPC]; Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 83021-546-30 | 83021054630 | 30 mL in 1 BOTTLE, DROPPER (83021-546-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 83021-546 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/83021-546 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 83021-546. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.